ReviewMolecular neurobiology2025
Aromatase as a Central Node in Astrocyte Health and Homeostasis.
Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aromatase is well recognized for its role in estrogen synthesis; however, most research to date has focused on neuronal aromatase, leaving its astrocyte-specific functions, such as homeostasis, inflammation, stress adaptation, and metabolic regulation, comparatively underexplored. Given the crucial roles of astrocytes and brain-derived estrogens in maintaining neural health and modulating disease processes, a deeper understanding of how aromatase shape astrocytic function has become increasingly necessary. Yet, attributing these effects solely to astrocytic aromatase is complicated by the paracrine and endocrine actions of estradiol. This scoping review synthesizes current evidence on how aromatase activity modulates astrocytic functions, identifies key knowledge gaps, and outlines priorities for future research. Using the Population, Concept, Context (PCC) framework, primary research studies across multiple species and experimental contexts were examined. The evidence consistently shows that astrocytic aromatase is upregulated following injury or stress, reflecting a conserved neuroprotective response mediated by local estrogen synthesis. Aromatase activity modulates neuroinflammation by suppressing pro-inflammatory cytokine production and limiting gliosis, while also enhancing astrocytic metabolic resilience, particularly under oxidative or nitrosative stress, thereby supporting neuronal fate in both in vitro and in vivo models. Across studies, sex differences have emerged, with female models often exhibiting higher aromatase expression and more pronounced neuroprotective effects. Despite compelling pre-clinical evidence, human-centered studies remain limited, thereby constraining the translational potential of current knowledge. Moreover, the molecular interplay between aromatase-driven estrogen signaling and other neurosteroidogenic pathways is not yet fully elucidated. Overall, while astrocytic aromatase appears to act as a pivotal regulator of CNS homeostasis and repair, particularly in the context of injury and neurodegeneration, current evidence does not fully disentangle its role from estradiol derived from neurons or systemic sources. These insights highlight its therapeutic potential for modulating inflammation and enhancing brain resilience and underscore the need for sex-specific, human-based research.
Indexed as
Identifiers
41387663What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.